Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders
Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders
Neumora Therapeutics 已啓動一項針對精神分裂症和其他神經精神疾病的健康成年參與者 NMRA-266 的 1 期單劑量遞增劑量/多劑量遞增劑量研究
Neumora Therapeutics 已啓動一項針對精神分裂症和其他神經精神疾病的健康成年參與者 NMRA-266 的 1 期單劑量遞增劑量/多劑量遞增劑量研究